06609.HK
Shanghai HeartCare Medical Technology Corporation Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 53.60
−0.74%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 513.8M | 408.3M | 277.9M | 232.3M | 183.0M |
| Cost of Revenue | 160.2M | 136.1M | 96.2M | 80.5M | 58.7M |
| Gross Profit | 353.6M | 272.2M | 181.7M | 151.8M | 124.3M |
| Operating Expenses | |||||
| R&D Expense | 41.1M | 40.8M | 58.9M | 123.8M | 153.7M |
| SG&A Expense | 214.2M | 187.1M | 137.8M | 153.9M | 168.0M |
| General & Admin Expense | 97.8M | 82.2M | 58.2M | 74.6M | 71.5M |
| Selling & Marketing Expense | 116.4M | 104.9M | 79.6M | 79.2M | 96.5M |
| Other Expenses | — | — | (8.8M) | — | (11.9M) |
| Total Operating Expenses | 255.3M | 227.9M | 188.0M | 277.7M | 309.8M |
| Cost and Expenses | 415.6M | 364.0M | 284.1M | 358.3M | 380.8M |
| Operating Income (EBIT) | 98.2M | 44.3M | (6.2M) | (125.9M) | (198.6M) |
| Non-Operating | |||||
| Interest Income | — | 6.2M | 8.8M | 11.2M | 15.1M |
| Interest Expense | — | 2.1M | 1.7M | 2.2M | 2.1M |
| Net Interest Income | 1.2M | 4.2M | 7.0M | 9.0M | 13.0M |
| Other Non-Op Income/Expense | 12.1M | 42.1M | (5.8M) | 23.0M | (3.4M) |
| Non-Operating Income (excl Interest) | 8.6M | 13.0K | 4.0M | (2.0M) | 13.6M |
| EBT (Pre-Tax Income) | 110.3M | 86.4M | (12.0M) | (102.9M) | (201.2M) |
| Income Tax Expense | 17.6M | 3.1M | 1.6M | (8.9M) | (865.0K) |
| Bottom Line | |||||
| Net Income | 92.8M | 83.3M | (13.6M) | (94.0M) | (200.4M) |
| Earnings from Cont. Ops | 92.8M | 83.3M | (13.6M) | (94.0M) | (200.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 92.8M | 83.3M | (13.6M) | (94.0M) | (200.4M) |
| Per Share | |||||
| Basic EPS | HK$2.48 | HK$2.21 | (HK$0.36) | (HK$2.47) | (HK$5.24) |
| Diluted EPS | HK$2.46 | HK$2.20 | (HK$0.36) | (HK$2.47) | (HK$5.24) |
| Revenue Per Share | HK$13.62 | HK$10.78 | HK$7.36 | HK$6.10 | HK$4.78 |
| Shares | |||||
| Basic Shares Outstanding | 37.7M | 37.9M | 37.8M | 38.1M | 38.3M |
| Diluted Shares Outstanding | 37.7M | 37.9M | 37.8M | 38.1M | 38.3M |
| Profitability Metrics | |||||
| EBITDA | 109.0M | 64.4M | 21.9M | (68.5M) | (167.3M) |
| D&A | 19.5M | 20.2M | 32.1M | 32.3M | 31.8M |
| EBIT | 89.6M | 44.3M | (10.2M) | (100.8M) | (199.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026